Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.

Tsimberidou AM, Levit LA, Schilsky RL, Averbuch SD, Chen D, Kirkwood JM, McShane LM, Sharon E, Mileham KF, Postow MA.

Open source

DOI
10.1186/s40425-018-0426-7
Published
2018-10-19
Container
J Immunother Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40425-018-0426-7,
  title = {Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.},
  author = {Tsimberidou AM and  Levit LA and  Schilsky RL and  Averbuch SD and  Chen D and  Kirkwood JM and  McShane LM and  Sharon E and  Mileham KF and  Postow MA.},
  year = {2018},
  journal = {J Immunother Cancer},
  doi = {10.1186/s40425-018-0426-7},
  url = {https://doi.org/10.1186/s40425-018-0426-7}
}

RIS

TY  - JOUR
TI  - Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.
AU  - Tsimberidou AM
AU  -  Levit LA
AU  -  Schilsky RL
AU  -  Averbuch SD
AU  -  Chen D
AU  -  Kirkwood JM
AU  -  McShane LM
AU  -  Sharon E
AU  -  Mileham KF
AU  -  Postow MA.
PY  - 2018
JO  - J Immunother Cancer
DO  - 10.1186/s40425-018-0426-7
UR  - https://doi.org/10.1186/s40425-018-0426-7
ER  - 

APA

AM, T., LA, L., RL, S., SD, A., D, C., JM, K., LM, M., E, S., KF, M., & MA., P. (2018). Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.. J Immunother Cancer. https://doi.org/10.1186/s40425-018-0426-7

Source records